Clinical Guidelines on the Management of Acute Bronchiolitis
Explanatory Notes on Level of Evidence and Grading System on Recommendation
The definition of types of evidence and grading recommendations originate from the US Agency for Health Care Policy and Research (AHCPR) and are also recommended and used by the Royal College of Paediatrics and Child Health.
Evidence is graded upon the methodological qualities. Guidelines normally contain many different recommendation based upon different levels of evidence. It is important that users are aware of the level of evidence on which each guideline recommendation is based. The link between guideline recommendation and the supporting evidence should be made explicit. Separating the strength of the recommendation from the level of evidence helps in situations where extrapolation is required to take the evidence of a methodologically strong study and apply it to the target population. Gradings of recommendation in addition to level of evidence allow more flexibility for future revision. However, it is important to emphasis that the grading does not relate to the importance of the recommendation.
Acute bronchiolitis is one of the most common lower respiratory infections suffered by infants. Studies have shown the local epidemiology is very much similar to that of the rest of the world. The present guideline aims to summarise the current evidence on the diagnosis and treatment of the condition, resulting in recommendations that are practicable both in the office and the hospital.
Definition of Bronchiolitis for This Guideline1
A. Age of 24 months or less
B. Expiratory wheezing of acute onset
C. Signs of viral respiratory illness such as coryza, otitis media, or fever
A review of the case definitions and inclusion criteria used in epidemiological studies and clinical trials revealed that many studies simply stated that infants with signs and symptoms consistent with bronchiolitis were eligible for inclusion. In others with more details, 43 trials used tachypnoea in the case definition or inclusion criteria; 42 used wheezing; 37 used oxygen saturation; and 32 used retractions.1 Notable differences of diagnostic criteria for bronchiolitis do exist among different studies. In America for example the term bronchiolitis seems to include a much wider range of illnesses. The North Carolina group whose epidemiological studies have been widely cited defined bronchiolitis as expiratory wheezing with or without tachypnoea, air trapping, and substernal retractions.2 The Rochester group had more restrictive diagnostic criteria: 1) expiratory wheezing of acute onset, 2) an age of 24 months or less, 3) signs of viral respiratory illness such as coryza, otitis media, or fever, 4) the first such episode, and 5) the presence or absence of indications of respiratory distress, pneumonia, or atopy.3 In U.K. or Australia the definition of bronchiolitis is generally even more restrictive. Studies of bronchiolitis have usually included only babies less than one year or 9 months.4,5 Some included only babies who had fine crepitations on physical examination.5
It is important to note that eligibility criteria in the clinical trials varied, especially with respect to criteria such as age, duration of symptoms, co-morbidities (e.g. prematurity and chronic lung disease), history of previous wheezing, and severity of disease. Specific study objectives determined most of these variations (e.g. some studies included only infants with first episode of wheeze with proven RSV infection, others included children with recurrent wheezing associated with any respiratory infection). Special attention should be given to the differential diagnoses between asthma and acute bronchiolitis during the appraisal of therapeutic trials, especially in infants, as the two conditions may bear many similarities in their presentation.
Aetiology and Epidemiology
As in Western countries, respiratory syncytial virus (RSV) is the commonest cause of acute bronchiolitis in Hong Kong. Other aetiological agents include parainfluenza and influenza viruses, adenoviruses, and mycoplasma pneumoniae. There are seasonal variations of incidence with a peak in the summer months, contrasting with winter outbreaks in Western countries.6
Clinical Features and Diagnosis3,7-10 (Level of evidence IV)
Diagnosis is based on clinical features:
Factors Associated with Severe Disease14-23 (Level of evidence III)
Indications for Hospital Admission13 (Level of evidence IV)
Indications for Admission to Paediatric Intensive Care Unit (PICU) 24 (Level of evidence IV)
1. Bordley WC, Viswanathan M, King VJ, et al. Diagnosis and testing in bronchiolitis: a systematic review. Arch Pediatr Adolesc Med 2004;158:119-26.
2. Denny FW, Collier AM, Henderson FW, Clyde WA Jr. The epidemiology of bronchiolitis. Pediatr Res 1977;11(3 Pt 2):234-6.
3. McConnochie KM. Bronchiolitis. What's in the name? Am J Dis Child 1983;137:11-3.
4. Wilson NM. Wheezy bronchitis revisited. Arch Dis Child 1989;64:1194-9.
5. Isaacs D. Bronchiolitis. BMJ 1995;310:4-5.
6. Sung RY, Chan RC, Tam JS, Cheng AF, Murray HG. Epidemiology and aetiology of acute bronchiolitis in Hong Kong infants. Epidemiol Infect 1992;108:147-54.
7. Reilly CM, Stokes J Jr, McClelland L, et al. Studies of acute respiratory illnesses caused by respiratory syncytial virus. 3. Clinical and laboratory findings. N Engl J Med 1961;264:1176-82.
8. Heycock JB, Noble TC. 1,230 cases of acute bronchiolitis in infancy. Br Med J 1962;5309:879-81.
9. Gardner PS. Respiratory syncytial virus infections. Postgrad Med J 1973;49:788-91.
10. Rakshi K, Couriel JM. Management of acute bronchiolitis. Arch Dis Child 1994;71:463-9.
11. Dawson KP, Long A, Kennedy J, Mogridge N. The chest radiograph in acute bronchiolitis. J Paediatr Child Health 1990;26:209-11.
12. Saijo M, Ishii T, Kokubo M, Murono K, Takimoto M, Fujita K. White blood cell count, C-reactive protein and erythrocyte sedimentation rate in respiratory syncytial virus infection of the lower respiratory tract. Acta Paediatr Jpn 1996;38:596-600.
13. Dawson K, Kennedy D, Asher I, et al. The management of acute bronchiolitis. Thoracic Society of Australia and New Zealand. J Paediatr Child Health 1993;29:335-7.
14. Simoes EA, Groothuis JR. Respiratory syncytial virus prophylaxis--the story so far. Respir Med 2002;96 Suppl B:S15-24.
15. Arnold SR, Wang EE, Law BJ, et al. Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada. Pediatr Infect Dis J 1999;18:866-9.
16. MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982;307:397-400.
17. Navas L, Wang E, de Carvalho V, Robinson J. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr 1992;121:348-54.
18. Moler FW, Khan AS, Meliones JN, Custer JR, Palmisano J, Shope TC. Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience. Crit Care Med 1992;20:1406-13.
19. Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986;315:77-81.
20. McConnochie KM, Roghmann KJ. Parental smoking, presence of older siblings, and family history of asthma increase risk of bronchiolitis. Am J Dis Child 1986;140:806-12.
21. Glezen WP. Pathogenesis of bronchiolitis--epidemiologic considerations. Pediatr Res 1977;11(3 Pt 2):239-43.
22. Vardas E, Blaauw D, McAnerney J. The epidemiology of respiratory syncytial virus (RSV) infections in South African children. S Afr Med J 1999;89:1079-84.
23. Harlap S, Davies AM. Infant admissions to hospital and maternal smoking. Lancet 1974;1:529-32.
24. Rakshi K, Couriel JM. Management of acute bronchiolitis. Arch Dis Child 1994;71:463-9.
25. Everard ML. Acute bronchiolitis-a perennial problem. The Lancet; London; Aug 3, 1996.
26. Gozal D, Colin AA, Jaffe M, Hochberg Z. Water, electrolyte, and endocrine homeostasis in infants with bronchiolitis. Pediatr Res 1990;27:204-9.
27. van Steensel-Moll HA, Hazelzet JA, van der Voort E, Neijens HJ, Hackeng WH. Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus. Arch Dis Child 1990;65:1237-9.
28. Khoshoo V, Edell D. Previously healthy infants may have increased risk of aspiration during respiratory syncytial viral bronchiolitis. Pediatrics 1999;104:1389-90.
29. Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. Arch Pediatr Adolesc Med 1996;150:1166-72.
30. Kellner JD, Ohlsson A, Gadomski AM, Wang EE. Bronchodilators for bronchiolitis (Cochrane Review). In: The Cochrane Library, Issue 4 2002. Oxford: Update Software.
31. Flores G, Horwitz RI. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997;100(2 Pt 1):233-9.
32. Schindler M. Do bronchodilators have an effect on bronchiolitis? Crit Care 2002;6:111-2.
33. Patel H, Platt RW, Pekeles GS, Ducharme FM. A randomized, controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis. J Pediatr 2002;141:818-24.
34. Hariprakash S, Alexander J, Carroll W, et al. Randomized controlled trial of nebulized adrenaline in acute bronchiolitis. Pediatr Allergy Immunol 2003;14:134-9.
35. Wainwright C, Altamirano L, Cheney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003;349:27-35.
36. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr 1995;126:1004-7.
37. Reijonen T, Korppi M, Pitkakangas S, Tenhola S, Remes K. The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. Arch Pediatr Adolesc Med 1995;149:686-92.
38. Bertrand P, Aranibar H, Castro E, Sanchez I. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis. Pediatr Pulmonol 2001;31:284-8.
39. Hartling L. Epinephrine for bronchiolitis (Review). The Cochrane Library, Volume(2). 2004.
40. Goebel J, Estrada B, Quinonez J, Nagji N, Sanford D, Boerth RC. Prednisolone plus albuterol versus albuterol alone in mild to moderate bronchiolitis. Clin Pediatr (Phila) 2000;39:213-20.
41. Schuh S, Coates AL, Binnie R, et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J Pediatr 2002;140:27-32.
42. Csonka P, Kaila M, Laippala P, Iso-Mustajarvi M, Vesikari T, Ashorn P. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial. J Pediatr 2003;143:725-30.
43. Garrison MM, Christakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: A meta-analysis. Pediatrics 2000;105:E44.
44. Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 1983;71:13-8.
45. Berger I, Argaman Z, Schwartz SB, et al. Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up. Pediatr Pulmonol 1998;26:162-6.
46. Zhang L, Ferruzzi E, Bonfanti T, et al. Long and short-term effect of prednisolone in hospitalized infants with acute bronchiolitis. J Paediatr Child Health 2003;39:548-51.
47. van Woensel JB, Wolfs TF, van Aalderen WM, Brand PL, Kimpen JL. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax 1997;52:634-7.
48. van Woensel JB, van Aalderen WM, de Weerd W, et al. Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax 2003;58:383-7.
49. Buckingham SC, Jafri HS, Bush AJ, et al. A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome. J Infect Dis 2002;185:1222-8.
50. Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children (Cochrane Review). The Cochrane Library, Issue 4, 2004.
51. King VJ, Viswanathan M, Bordley WC, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med 2004;158:127-37.
52. Friis B, Andersen P, Brenoe E, et al. Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. Arch Dis Child 1984;59:1038-45.
53. Hall CB, Powell KR, Schnabel KC, Gala CL, Pincus PH. Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. J Pediatr 1988;113:266-71.
54. Chipps BE, Sullivan WF, Portnoy JM. Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus. Pediatr Infect Dis J 1993;12:653-8.
55. Sung RY, Yin J, Oppenheimer SJ, Tam JS, Lau J. Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a. Arch Dis Child 1993;69:440-2.
56. Kjolhede CL, Chew FJ, Gadomski AM, Marroquin DP. Clinical trial of vitamin A as adjuvant treatment for lower respiratory tract infections. J Pediatr 1995;126(5 Pt 1):807-12.
57. Tibby SM, Hatherill M, Wright SM, Wilson P, Postle AD, Murdoch IA. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000;162(4 Pt 1):1251-6.
58. Kong XT, Fang HT, Jiang GQ, Zhai SZ, O'Connell DL, Brewster DR. Treatment of acute bronchiolitis with Chinese herbs. Arch Dis Child 1993;68:468-71.
59. Perlstein PH, Kotagal UR, Bolling C, et al. Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics 1999;104:1334-41.
60. Webb MS, Martin JA, Cartlidge PH, Ng YK, Wright NA. Chest physiotherapy in acute bronchiolitis. Arch Dis Child 1985;60:1078-9.
61. Gibson LE. Use of water vapor in the treatment of lower respiratory disease. Am Rev Respir Dis 1974;110(6 Pt 2):100-3.